We have previously achieved total survival of B16 melanoma-bearing mice in a preventive vaccine model using freshly GM-CSF transfected (non-selected) B16 cells (Moret-Tatay et al. 2003; Herrero et al. 2006; Herrero et al. 2008). This evidence concerns the gene CSF2 and melanoma.